EMAP-II, Endothelial-Monocyte Activating Polypeptide II, human: EMAP-II is a tumor derived cytokine that exerts a wide range of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculogenesis, neovessel formation, and can induce apoptosis. It is also chemotactic towards neutrophils and monocytes and induces myeloperoxidase activity from neutrophils. Of clinical importance, EMAP-II inhibits angiogenesis of vascular beds and suppresses the growth of primary and secondary tumors without affecting normal tissues. Mature EMAP-II is an 18.3 kDa protein, which is synthesized as the C-terminal portion of a biologically inactive precursor protein containing a propeptide of 146 amino acid residues. UnitProt ID: Q12904
EMAP-II, Endothelial-Monocyte Activating Polypeptide II, human
£114.00 exc. VAT
5ug
CAS | |
---|---|
Grade | |
HS Code | 2937.19.0000 |
Manufacturer | Bio Basic |
Pack Size | 5ug |
Shipping Conditions | ICE |
Sterile | yes |
Storage Conditions | (-15 to -20)C |
UNSPSC Category | Other Cytokines and Chemokines |
UNSPSC Code | 41116127 |
DG | |
Hazard Class | |
Hazard UN |